– Ionis-authored research also recognized with Paper of the Year honor
CARLSBAD, Calif., Oct. 1, 2020 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in antisense therapeutics, announced today that Frank Bennett, Ph.D., Ionis’ executive vice president and chief scientific officer, has been awarded the 2020 Lifetime Achievement Award by the Oligonucleotide Therapeutics Society (OTS). Dr. Bennett was recognized by the OTS Award Committee for his important contributions to basic science and for being instrumental in the development of antisense oligonucleotide drugs that modulate splicing to correct severe genetic disease.
A founding member of Ionis, Dr. Bennett is responsible for continuing to advance antisense technology and expanding Ionis’ drug discovery platform. He is also the franchise leader for neurological programs at Ionis. Dr. Bennett is a co-recipient of the 2019 Breakthrough Prize in Life Sciences for his contributions to the discovery and development of
William Kaplan who has over 106 credits to his name will be honored by the Cinema Audio Society with its highest accolade, a Career Achievement Award.
The seven-time Oscar nominee, who has worked on films such as “Crimson Tide,” “Top Gun” and “Back to the Future,” will be honored at the 57th CAS Awards on April 17.
The location for the event is yet to be determined and will either be live in downtown Los Angeles or virtual due to the coronavirus pandemic.
“The Cinema Audio Society is delighted to bestow the honor of Career Achievement to Mr. William B. Kaplan CAS,” said CAS President Urban. “His work consists of decades of exceptional filmmaking. Many of the fruits of his labor remain forever in our hearts and minds as exemplary works of art and staples of global popular culture. His professional journey is an inspiring tale of adventure, not unlike